JLE

European Journal of Dermatology

MENU

Efficacy and safety of abrocitinib for the treatment of adolescents and adults with moderate-to-severe atopic dermatitis: update of a living systematic review and meta-analysis Volume 33, numéro 5, September-October 2023

Citer cet article

Citation de l'article, à la forme « Vancouver » :

Hui Zheng, Yan Chen, Yunsheng Xu, Xinjie Deng. Efficacy and safety of abrocitinib for the treatment of adolescents and adults with moderate-to-severe atopic dermatitis: update of a living systematic review and meta-analysis. European Journal of Dermatology. 2023;33(5):530-543. doi:10.1684/ejd.2023.4557

Télécharger (RIS) Ajouter dans ma bibliographie

Les citations dans ma bibliographie.